Highlights • Tilorone dihydrochloride possesses robust anti-SFTSV activity in vitro and in vivo.• Intraperitoneal administration of tilorone leads to protection against intracranial lethal challenge of SFTSV.• The anti-SFTSV mechanism of… Click to show full abstract
Highlights • Tilorone dihydrochloride possesses robust anti-SFTSV activity in vitro and in vivo.• Intraperitoneal administration of tilorone leads to protection against intracranial lethal challenge of SFTSV.• The anti-SFTSV mechanism of tilorone is through stimulation of host innate immunity.• Pre-treatment with tilorone can prevent mice from lethal SFTSV challenge.
               
Click one of the above tabs to view related content.